Results 171 to 180 of about 59,883 (231)

The therapeutic potential of <i>Ziziphus jujuba</i> in colorectal cancer: An <i>in-vitro</i> study. [PDF]

Avicenna J Phytomed
Pourali G, Moetamani-Ahmadi M, Alaei M, Fiuji H, Fathi A, Maftooh M, Khazaei M, Ferns GA, Hassanian SM, Avan A.   +9 more
europepmc   +1 more source

Gemcitabine plus selinexor in selective advanced sarcomas: a phase I of the Spanish group for research on sarcoma study. [PDF]

Nat Commun
Martin-Broto J, Casado A, Marquina G, Redondo A, Martinez-Trufero J, Valverde C, Gutierrez A, Bernabeu D, Ortega L, Merino J, Ramos R, Ledesma P, Mondaza-Hernandez JL, Moura DS, Hindi N.   +14 more
europepmc   +1 more source

Survivin Is a Central Mediator of Cell Proliferation in HPV-Negative Head and Neck Squamous Cell Carcinoma. [PDF]

Cancers (Basel)
Zhu J, An J, Hu E, Rosenblatt G, Berner G, Roy A, Kawachi N, Shrivastava N, Mehta V, Segall JE, Prystowsky MB, Ow TJ.   +11 more
europepmc   +1 more source

Inhibition of Caspase-3 and -9 by Survivin and its splice variants Survivin-DeltaEx3, Survivin-2B and Survivin-3B

, 2006
Wagener, J, Gabbert, HE, Mahotka, C
openaire   +1 more source

Inhibition of fatty acid synthase enhances therapeutic efficacy and delays acquired resistance to BRAF-targeted therapy in colorectal cancer. [PDF]

Neoplasia
Geisen ME, Tessmann JW, Kelson CO, He D, Wang C, Faisal ASM, Beswick EJ, Baca Y, Rock S, Kolesar JM, Zaytseva YY.   +10 more
europepmc   +1 more source

Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer. [PDF]

Sci Rep
Ahmadi SF, Arab SS, Samadikhah H.
europepmc   +1 more source

7-Ketocholesterol Links Sterol Homeostasis to Hedgehog Signaling and Stress-Survival Responses in MSCs from Patients with Acute Myeloid Leukemia. [PDF]

Int J Mol Sci
Reichert CO, Levy D, Freitas FA, Silva JS, Barros PL, Paz JL, Nunes JPS, Cunha-Neto E, Kalil J, Giglio PN, Demange MK, Culler HF, Lage LAPC, Rodrigues A, Pereira J, Bydlowski SP.   +15 more
europepmc   +1 more source

[Corrigendum] Src homology phosphotyrosyl phosphatase 2 mediates cisplatin‑related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells. [PDF]

Oncol Rep
Yin Y, Tang L, Shi L.
europepmc   +1 more source

Research Progress on Polymer-Based Nanocarriers for Tumor-Targeted Delivery of Survivin siRNA. [PDF]

Polymers (Basel)
Ren L, Wang S, Li BC, Ding GB.
europepmc   +1 more source

Corrigendum: Survivin (BIRC5) regulates bladder fibrosis in a rat model of partial bladder outlet obstruction. [PDF]

Chin Med J (Engl)
europepmc   +1 more source